  See all
 |
Articles: BMT/SCT |
Prior Articles
Prior treatment with Gemtuzumab Ozogamicin and the risk of veno-occlusive disease after allogeneic haematopoietic stem cell transplantation
Bone Marrow Transplantation, 07/08/09
Comparison between filgrastim and lenograstim plus chemotherapy for mobilization of PBPCs
Bone Marrow Transplantation, 07/08/09 Interindividual variation of maximal blood levels of tacrolimus after its oral administration in hematopoietic cell transplant recipients
Transplantation Proceedings, 07/07/09 Dimethyl Sulfoxide-Induced Toxicity in Cord Blood Stem Cell Transplantation: Report of Three Cases and Review of the Literature
Acta Haematologica, 07/07/09 Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma
British Journal of Haematology, 07/06/09 Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma
Annals of Oncology, 07/06/09 Influence of oral beclomethasone dipropionate on early non-infectious pulmonary outcomes after allogeneic hematopoietic cell transplantation: results from two randomized trials
Bone Marrow Transplantation, 07/01/09 Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies
Bone Marrow Transplantation, 07/01/09 Infections in non-myeloablative hematopoietic stem cell transplantation patients with lymphoid malignancies: spectrum of infections, predictors of outcome and proposed guidelines for fungal infection prevention
Bone Marrow Transplantation, 07/01/09 Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection
Bone Marrow Transplantation, 07/01/09 Predictors of avascular necrosis of bone in long-term survivors of hematopoietic cell transplantation
Cancer, 07/01/09 Mental status changes after hematopoietic stem cell transplantation
Cancer, 06/30/09 Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide, lenalidomide or bortezomib- containing regimens
Blood, 06/29/09 Increased serum levels of matrix metalloproteinase-9 in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
International Journal of Hematology, 06/26/09 Yttrium-90-ibritumomab tiuxetan in combination with intravenous busulfan, cyclophosphamide, and etoposide followed by autologous stem cell transplantation in patients with relapsed or refractory B-cell non-Hodgkins lymphoma
Investigational New Drugs, 06/26/09
Free full text
Safety and efficacy assessment of plerixafor in patients with multiple myeloma proven or predicted to be poor mobilizers, including assessment of tumor cell mobilization
Bone Marrow Transplantation, 06/24/09 Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant
American Journal of Hematology, 06/24/09 Rearrangements of the MLL gene are influenced by DNA secondary structure, potentially mediated by topoisomerase II binding
Genes, Chromosomes and Cancer, 06/23/09 Reliability of a pretransplant i.v. BU test dose performed 2 weeks before myeloablative FluBu conditioning regimen
Bone Marrow Transplantation, 06/23/09
Exclusive Author Commentary 5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation
Bone Marrow Transplantation, 06/23/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
|
|
